Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Marketsnovo nordiskaidrug discovery

Novo Nordisk Turns to AI to Reshape Drug Discovery

The Danish drugmaker is applying artificial intelligence across its research pipeline, according to an investor-focused analysis.

TR
By Tom Reyes · Markets Editor
Sep 16 14:36 ETSource: simplywall.st

The wire

  1. 01Novo Nordisk is deploying AI tools in drug discovery, per a Simply Wall St analysis.
  2. 02Novo is the largest GLP-1 maker, so research productivity shifts carry sector-wide weight.
  3. 03No specific programs, partners or timelines were detailed in the item.

From the source

Novo Nordisk (CPSE:NOVO B) Taps AI To Reshape Drug Discovery

Read at news.google.com
Source URL https://news.google.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?oc=5